Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-13 · accession 0001415889-25-001496 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-15 | 2025-01-13 | KNSA | Tessari Eben | COO | S - Sale+OE | $18.24 | -14.0K | 90.7K | -13% | -$255.4K |
| D | 2025-01-15 | 2025-01-13 | KNSA | Tessari Eben | COO | M - OptEx | $3.80 | +7,000 | 103.0K | +7% | +$26.6K |
| D | 2025-01-15 | 2025-01-13 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -7,000 | 28.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-01-13 | S | D | 1,677 | $19.08 | 88,975 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $18.92 and $19.39. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-01-13 | M | A | 7,000 | $3.80 | 102,975 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-01-13 | S | D | 12,323 | $18.13 | 90,652 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $17.92 and $18.89. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Derivative | Share Option | 2025-01-13 | M | D | 7,000 | $0.00 | 28,049 | D | $3.80 · — to 2027-06-28 | 7,000 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |